Separator including coating layer of inorganic and organic mixture, and battery including the same
    2.
    发明授权
    Separator including coating layer of inorganic and organic mixture, and battery including the same 有权
    分离器包括无机和有机混合物的涂层,以及包括其的电池

    公开(公告)号:US09412988B2

    公开(公告)日:2016-08-09

    申请号:US13778438

    申请日:2013-02-27

    Abstract: A porous separator including a porous base film; and a coating layer, the coating layer being on a surface of the porous base film and including a polyvinylidene fluoride homopolymer, a polyvinylidene fluoride-hexafluoropropylene copolymer, and inorganic particles, wherein the separator exhibits a thermal shrinkage of about 30% or less in a machine direction (MD) or in a transverse direction (TD), as measured after leaving the separator at 150° C. for 1 hour, a peel strength of about 50 gf/cm2 or more between the coating layer and the base film, and an adhesive strength of about 20 gf/cm2 or more between the coating layer and electrodes of a battery.

    Abstract translation: 一种多孔隔膜,包括多孔基膜; 以及涂层,所述涂层位于所述多孔基材膜的表面上,并且包含聚偏二氟乙烯均聚物,聚偏二氟乙烯 - 六氟丙烯共聚物和无机颗粒,其中所述隔膜的热收缩率为约30%以下 机器方向(MD)或横向(TD),在离子分离器在150℃下测量1小时,涂层和基膜之间的剥离强度为约50gf / cm 2以上,以及 在涂层和电池的电极之间的粘合强度为约20gf / cm 2以上。

    SEPARATOR INCLUDING COATING LAYER AND BATTERY INCLUDING THE SAME
    3.
    发明申请
    SEPARATOR INCLUDING COATING LAYER AND BATTERY INCLUDING THE SAME 有权
    分离器包括涂层和电池,包括它们

    公开(公告)号:US20130224552A1

    公开(公告)日:2013-08-29

    申请号:US13778259

    申请日:2013-02-27

    CPC classification number: H01M2/1686 H01M2/1653 H01M2/166 H01M10/052

    Abstract: A separator includes a polyolefin base film and a coating layer, the coating layer containing inorganic particles having an average particle size of about 1 nm to about 700 nm and an organic binder of a polyvinylidene fluoride homopolymer, the coating layer having a density of about 1.2 g/m3 to about 2 g/m3, the coating layer being disposed on one or both sides of the base film.

    Abstract translation: 隔膜包括聚烯烃基膜和涂层,所述涂层含有平均粒度为约1nm至约700nm的无机颗粒和聚偏二氟乙烯均聚物的有机粘合剂,所述涂层的密度为约1.2 g / m 3至约2g / m 3,涂层设置在基膜的一侧或两侧。

    PORTABLE INTERNET RADIO ACCESS STATION INCLUDING MULTIPLE MANAGEMENT PROCESSORS AND METHOD OF CONTROLLING THE MULTIPLE MANAGEMENT PROCESSORS
    4.
    发明申请
    PORTABLE INTERNET RADIO ACCESS STATION INCLUDING MULTIPLE MANAGEMENT PROCESSORS AND METHOD OF CONTROLLING THE MULTIPLE MANAGEMENT PROCESSORS 有权
    便携式互联网无线接入站,包括多个管理处理器和控制多个管理处理器的方法

    公开(公告)号:US20090154435A1

    公开(公告)日:2009-06-18

    申请号:US12300041

    申请日:2007-05-23

    CPC classification number: H04W88/08 H04W24/00

    Abstract: The present invention relates to a portable internet radio access station, and more particularly, to a portable internet radio access station including a plurality of management processors and a method of controlling the plurality of management processors. A first management processor of a portable internet radio access station according to the present invention includes: an obstruction sensing unit sensing an obstruction in the first and second management processors; a call processing database storing a call processing information of the portable internet radio access station; an operation state determining unit determining an operation state of the first management processor based on the obstruction; and a database synchronizing unit synchronizing the call processing database with a call processing database of the second management processor based on the operation state of the first management processor Accordingly, continuity and reliability in call processing are obtained in the portable internet radio access station of the present invention.

    Abstract translation: 便携式无线电接入站技术领域本发明涉及一种便携式无线电接入站,更具体地,涉及包括多个管理处理器的便携式因特网无线电接入站和控制多个管理处理器的方法。 根据本发明的便携式因特网无线电接入站的第一管理处理器包括:障碍物感测单元,感测第一和第二管理处理器中的障碍物; 呼叫处理数据库,存储便携式无线电接入站的呼叫处理信息; 操作状态确定单元,基于所述障碍物确定所述第一管理处理器的操作状态; 以及基于第一管理处理器的操作状态的呼叫处理数据库与第二管理处理器的呼叫处理数据库同步的数据库同步单元。因此,在本发明的便携式无线电接入站中获得呼叫处理中的连续性和可靠性 发明。

    Target-Specific Non-Antibody Protein and Method for Preparing the Same
    6.
    发明申请
    Target-Specific Non-Antibody Protein and Method for Preparing the Same 有权
    靶向特异性非抗体蛋白及其制备方法

    公开(公告)号:US20120071419A1

    公开(公告)日:2012-03-22

    申请号:US13264365

    申请日:2010-04-14

    Abstract: The present invention relates to a method for preparing a target-specific non-antibody protein, and more particularly, to a method for preparing a target-specific non-antibody protein comprising the steps of: selecting non-antibody proteins having a structural complementarity with the target site of a target protein in a non-antibody protein library; calculating a binding energy of the selected non-antibody protein and the target protein; selecting a non-antibody protein having a favorable binding energy among the selected non-antibody proteins; selecting amino acid residues having a high binding energy among the interfacial amino acid residues of the selected non-antibody protein and the target protein; and substituting the selected amino acid residues with the amino acid residues having a low binding energy. In addition, the present invention relates to a target-specific non-antibody specifically binding with EGFR (Epidermal Growth Factor Receptor) domain 2, which is prepared by the method, and a cancer therapeutic composition comprising the same.

    Abstract translation: 本发明涉及一种制备靶特异性非抗体蛋白质的方法,更具体地涉及一种制备靶特异性非抗体蛋白质的方法,包括以下步骤:选择具有结构互补性的非抗体蛋白质 非抗体蛋白文库中靶蛋白的靶位点; 计算所选择的非抗体蛋白质和靶蛋白质的结合能; 选择所选非抗体蛋白质中具有良好结合能的非抗体蛋白质; 选择所选非抗体蛋白质的界面氨基酸残基与目标蛋白质之间具有高结合能的氨基酸残基; 并用具有低结合能的氨基酸残基代替所选择的氨基酸残基。 此外,本发明涉及通过该方法制备的与EGFR(表皮生长因子受体)结构域2特异性结合的靶特异性非抗体,以及含有该特异性抗体的癌症治疗组合物。

    Liquid crystal display device formed on glass substrate having improved efficiency
    7.
    发明授权
    Liquid crystal display device formed on glass substrate having improved efficiency 有权
    在玻璃基板上形成的提高效率的液晶显示装置

    公开(公告)号:US06839121B2

    公开(公告)日:2005-01-04

    申请号:US10317176

    申请日:2002-12-12

    CPC classification number: G02F1/1309 G02F2001/136254

    Abstract: An LCD device includes a displaying unit having a plurality of pixel areas defined by a plurality of gate lines and data lines disposed in longitudinal and transverse directions, a thin film transistor (TFT) formed in each of the pixel areas to be connected to a pixel electrode formed in the pixel area, and a gate pad and a data pad formed on ends of the corresponding gate line and data line; and a dummy region formed on an outer portion of the displaying unit, and including a gate shorting bar and a data shorting bar which are connected to the gate pads and the data pads to apply test signal(s) to the TFTs, wherein at least one of the gate shorting bar and the data shorting bar is a single shorting bar.

    Abstract translation: 一种液晶显示装置,具有显示单元,具有由多个栅极线和沿纵向和横向设置的数据线所限定的多个像素区域,形成在每个像素区域中以与像素连接的薄膜晶体管(TFT) 形成在像素区域中的电极,以及形成在对应的栅极线和数据线的端部上的栅极焊盘和数据焊盘; 以及形成在所述显示单元的外部部分上的虚拟区域,并且包括连接到所述栅极焊盘和所述数据焊盘的栅极短路棒和数据短路棒,以将测试信号施加到所述TFT,其中至少 门短路棒和数据短路棒之一是单个短路棒。

    HUMAN RESISTIN RECEPTOR AND USE THEREOF
    10.
    发明申请
    HUMAN RESISTIN RECEPTOR AND USE THEREOF 有权
    人类抑制素受体及其用途

    公开(公告)号:US20140171489A1

    公开(公告)日:2014-06-19

    申请号:US14237518

    申请日:2012-08-07

    CPC classification number: G01N33/564 G01N33/6863 G01N2333/715

    Abstract: The present invention concerns a human resistin receptor. More particularly, the present invention provides a method for screening a receptor of human resistin protein, a method for preventing or treating an inflammatory disease and arteriosclerosis using an expression- or activity-regulator for a human resistin receptor, and a pharmaceutical composition including an expression- or activity-regulator for the human resistin receptor. The method for screening a human resistin protein receptor according to the present invention enables separation of a receptor which directly binds to resistin from human monocyte, reveals a mechanism of signal transduction of the resistin receptor, and therefore, is expected to contribute to regulation of an inflammatory effect of monocyte, molecular detection of causes for vascular inflammation and arteriosclerosis, and developments of prevention and a treating agent for an inflammatory disease and arteriosclerosis.

    Abstract translation: 本发明涉及人抵抗素受体。 更具体地,本发明提供了筛选人抵抗素蛋白的受体的方法,使用人抵抗素受体的表达或活性调节剂预防或治疗炎症性疾病和动脉硬化的方法,以及包含表达 - 或人抵抗素受体的活性调节剂。 根据本发明的用于筛选人抵抗素蛋白受体的方法使得能够从人单核细胞中分离直接结合抵抗素的受体,揭示了抵抗素受体信号转导的机制,因此预期有助于调节 单核细胞的炎症作用,血管炎症和动脉硬化原因的分子检测,以及预防和炎性疾病和动脉硬化治疗剂的发展。

Patent Agency Ranking